ATE188706T1 - Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels - Google Patents

Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels

Info

Publication number
ATE188706T1
ATE188706T1 AT92115730T AT92115730T ATE188706T1 AT E188706 T1 ATE188706 T1 AT E188706T1 AT 92115730 T AT92115730 T AT 92115730T AT 92115730 T AT92115730 T AT 92115730T AT E188706 T1 ATE188706 T1 AT E188706T1
Authority
AT
Austria
Prior art keywords
producing
nuclear inhibitor
medicinal product
nuclear
inhibitor
Prior art date
Application number
AT92115730T
Other languages
English (en)
Inventor
Juergen Weitz
Michael Stoehr
Inge Napierski
Hans-Dieter Royer
Marijana Kopun
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of ATE188706T1 publication Critical patent/ATE188706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92115730T 1991-10-09 1992-09-15 Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels ATE188706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91117184 1991-10-09

Publications (1)

Publication Number Publication Date
ATE188706T1 true ATE188706T1 (de) 2000-01-15

Family

ID=8207249

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92115730T ATE188706T1 (de) 1991-10-09 1992-09-15 Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels

Country Status (8)

Country Link
US (1) US6045831A (de)
EP (1) EP0536563B1 (de)
JP (1) JPH06245787A (de)
AT (1) ATE188706T1 (de)
AU (1) AU669129B2 (de)
CA (1) CA2080182C (de)
DE (1) DE69230550T2 (de)
ES (1) ES2140402T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0744808B2 (ja) * 1987-02-19 1995-05-15 ▲えな▼吉 早坂 磁気制御同性磁極誘導発電機
US20040022764A1 (en) * 2002-07-31 2004-02-05 Hanan Polansky Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease

Also Published As

Publication number Publication date
CA2080182C (en) 2002-12-10
AU669129B2 (en) 1996-05-30
AU2627892A (en) 1993-04-22
JPH06245787A (ja) 1994-09-06
EP0536563B1 (de) 2000-01-12
DE69230550D1 (de) 2000-02-17
US6045831A (en) 2000-04-04
ES2140402T3 (es) 2000-03-01
CA2080182A1 (en) 1993-04-10
DE69230550T2 (de) 2000-05-25
EP0536563A1 (de) 1993-04-14

Similar Documents

Publication Publication Date Title
ATE91399T1 (de) Matrize fuer die dentalmedizin und eine vorrichtung zur herstellung von matrizenbaendern.
BR9206027A (pt) Análogo de oligonucleotídio, composto de subunidade de oligonucleotídeo, processo para preparar tal composto, processo para modular a produção ou atividade de uma proteína, e, processo para tratar um organismo tendo uma doença distinta pela produção indesejada de uma proteína
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
DE69913665D1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
DE69333866D1 (de) Gerät zur medizinischen Ultraschallbehandlung unter Verwendung von Computertomographie
EP0787802A3 (de)
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE188706T1 (de) Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels
MX9200106A (es) Depresor anatomico lingual, desechable y esteril, para la exploracion del istmo de las fauces y la laringe
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE3578374D1 (de) Verwendung von chinolonen fuer die herstellung eines arzneimittels zur behandlung von herzerkrankungen.
DE69011465D1 (de) Verwendung von Human-ADF (=Adult T-cell leukemia-derived factor) zur Herstellung von Medikamenten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee